Evidence map›Paper›PMID 41904697›Full record

ArticleMedical physics2026

Independent verification of vendor-issued dosimetric data for

Simon Dahlander, Ilias Billas, Thorsten Sander, Graham Bass, Linda Persson, Åsa Carlsson Tedgren

Abstract read
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simon DahlanderDepartment of Oncology Pathology, Karolinska Institute, Stockholm, Sweden.
Ilias BillasNational Physical Laboratory, Teddington, UK.
Thorsten SanderNational Physical Laboratory, Teddington, UK.
Graham BassNational Physical Laboratory, Teddington, UK.
Linda PerssonDepartment of Oncology Pathology, Karolinska Institute, Stockholm, Sweden.
Åsa Carlsson TedgrenDepartment of Oncology Pathology, Karolinska Institute, Stockholm, Sweden.

Funding

Swedish Cancer Foundation 240927FKSwedish Cancer Foundation 243786PJSwedish Radiation Safety Authority SSM2022-6507
6 · The paper itself

Abstract

backgroundIndependent verification of the manufacturer-provided dosimetry data for PURPOSE: This work establishes a complete framework for traceable absorbed dose to water measurements of

methodsThree microSilicon diode detectors were calibrated in traceable

resultsThe MC-calculated correction factors for the diodes showed a significant depth-dependence, underscoring the necessity of such corrections in the steep

conclusionsWe present a novel, comprehensive methodology for independent and traceable absolute dosimetry of

Indexed as

BrachytherapyRadiation DosageRadiometryRuthenium RadioisotopesWaterCalibrationMonte Carlo MethodRadiotherapy DosageReference StandardsRuthenium-106Ruthenium RadioisotopesWaterdosimetryMonte CarloRu‐106 brachytherapytraceable metrology

Identifiers

PMID41904697
PMCPMC13033280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.